M. Vercruyssen , A. Van den Broeke , A. Salaroli , P. Nguyen , A. De Wind , N. Meuleman MD, PhD, D. Bron MD, PhD
SUMMARY
Human T-cell leukaemia virus type 1 (HTLV-1) was the first human oncogenic virus discovered. It is endemic in some regions of the world but increasingly prevalent in our countries as globalisation is progressing. After several decades of asymptomatic carrying, approximately 2–5% of infected individuals will develop adult-T-cell leukaemia-lymphoma (ATL). Despite significant progress in the physiopathology and therapeutic interventions, the prognosis of this rare disease is dismal. An update of classification, clinical features, diagnosis and recent treatment recommendations is outlined in this review.
BJH - volume 8, issue Abstract Book BHS, february 2017
D. Bron MD, PhD, A. Salaroli , N. Meuleman MD, PhD, M. Maerevoet MD, M. Vercruyssen , C. Spilleboudt , A. De Wind , G. Dapri , G.B. Cadiere , B. Cadiere
Top
